Metro Minnesota CCOP-St. Johns is a clinical research site located in Maplewood, Minnesota, United States 55109.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
Metro Minnesota CCOP-St. Johns has participated in 1 clinical trials.
Therapeutic areas: Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma.
Sponsors: CTI BioPharma.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Metro Minnesota CCOP-St. Johns has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Metro Minnesota CCOP-St. Johns has 1 clinical trials on record. Their work covers Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma.
Metro Minnesota CCOP-St. Johns has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.